VdA is highlighted in the Portuguese media for assisting Lusomedicamenta - Sociedade Técnica Farmacêutica S.A., a Portuguese company part of the Recipharm AB group with experience in the pharmaceutical sector, with two transactions in the total amount of 31 million euros.
The first trasnsaction involved the sale of Lusomedicamenta’s distribution business, represented by its “Medicamenta” business unit with a focus on cardiovascular, respiratory and metabolic diseases, to Laboratório Medinfar - Produtos Farmacêuticos, S.A., and the second involved the sale of all shares representing the share capital of its subsidiary company, DAVI II Farmacêutica, S.A., to a private buyer.

This was one of the most important deals in the Portuguese pharmaceutical market during 2020, involving two leading market players, with Medinfar having strengthened its market position through the acquisition of this business unit.

VdA’s team brought together lawyers from its M&A, Health and Labour Law practice areas, namely Rita Marques (Senior Adviser), Tiago Piló, Pedro Fontes (Managing Associates), Isa Rodrigues, João Francisco Barreiros and Philippa Soares Franco (Associates).